Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'bioSpec': {'retention': 'SAMPLES_WITH_DNA', 'description': 'urine samples'}, 'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'CASE_CONTROL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 90}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2020-06-24', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-01', 'completionDateStruct': {'date': '2024-12', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2023-01-03', 'studyFirstSubmitDate': '2022-09-22', 'studyFirstSubmitQcDate': '2023-01-03', 'lastUpdatePostDateStruct': {'date': '2023-01-06', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2023-01-06', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2024-12', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Detection of metallophores', 'timeFrame': 'through study completion, an average of 1 year', 'description': 'The detection of metallophores in urine samples'}, {'measure': 'Classification of microorganisms', 'timeFrame': 'through study completion, an average of 1 year', 'description': 'Taxonomic classification of the pathogenic microorganism using its metallophores'}], 'secondaryOutcomes': [{'measure': 'Metallophores versus culture', 'timeFrame': 'through study completion, an average of 1 year', 'description': 'The comparison of standard urinary culture results with those obtained from mass spectrometry analysis'}, {'measure': 'Cases versus Controls 1 versus Controls 2', 'timeFrame': '1 year after study completion', 'description': 'The comparison of the detection of metalophores in cases with AP/cUTI versus acute uncomplicated cystitis versus urinary tract infection-free individuals'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['metallophores', 'mass spectrometry', 'acute pyelonephritis', 'complicated urinary tract infection', 'siderophores', 'yersiniabactin'], 'conditions': ['Acute Pyelonephritis', 'Complicated Urinary Tract Infection']}, 'referencesModule': {'references': [{'type': 'BACKGROUND', 'citation': 'Bonkat G, Bartoletti R, Bruyère F, Cai T, Geerlings SE, Köves B, et al. Guidelines on Urological Infections. 2020. Vallejo-Torres L, Pujol M, Shaw E, Wiegand I, Vigo JM, Stoddart M, et al. Cost of hospitalised patients due to complicated urinary tract infections: A retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: The COMBACTE-MAGNET, RESCUING study. BMJ Open 2018;8:1-9. https://doi.org/10.1136/bmjopen-2017-020251. Hrbacek J, Cermak P, Zachoval R. Current antibiotic resistance trends of uropathogens in central europe: Survey from a tertiary hospital urology department 2011-2019. Antibiotics 2020;9:1-11. https://doi.org/10.3390/antibiotics9090630. Hyun M, Noh CI, Ryu SY, Kim HA. Changing trends in clinical characteristics and antibiotic susceptibility of Klebsiella pneumoniae bacteremia. Korean J Intern Med 2018;33:595-603. Caza M, Kronstad J. Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans. Front Cell Infect Microbiol 2013;4:1-23. https://doi.org/10.3389/fcimb.2013.00080. Prichystal J, Schug K, Lemr K, Novak J, Havlicek V. Structural analysis of natural products. Anal Chem 2016;88:10338-46. Václavková J, Ozdian T, Hajdúch M, Džubák P. Body fluids as a source of prote-omic biomarkers of various diseases. Chem List 2020;114:209-15 Skriba A, Pluhacek T, Palyzova A, Novy Z, Lemr K, Hajduch M, et al. Early and non-invasive diagnosis of aspergillosis revealed by infection kinetics monitored in a rat model. Front Microbiol 2018;9:1-7. https://doi.org/10.3389/fmicb.2018.02356. Hrbacek J, Morais D, Cermak P, Hanacek V, Zachoval R. Alpha-diversity and microbial community structure of the male urinary microbiota depend on urine sampling method. Sci Rep 2021;11. https://doi.org/10.1038/s41598-021-03292-x.'}]}, 'descriptionModule': {'briefSummary': 'The project aims to investigate bacterial metallophores as potential diagnostic markers of acute pyelonephritis and complicated urinary tract infections. These secondary metabolites are excreted by pathogenic microorganims in the course of infection for the uptake of iron and other metallic ions from the host. They are species-specific and can be detected in body fluids (including urine) by mass spectrometry. The potential contribution of this project is a culture-independent method for the diagnosis of the causative microbiological agent.', 'detailedDescription': 'Acute pyelonephritis (AP) is a clinical syndrome characterized by fever, chills, nausea vomiting and costovertebral angle tenderness, bacteriuria and pyuria. The underlying pathophysiology is based on the presence of microbes in the renal parenchyma which may progress to sepsis. Complicated urinary tract infection (cUTI) is one accompanied by abnormalities of the urinary tract or host factors which make the eradication of the infection difficult.\n\nThe most common etiological agents include gram-negative enteric rods, i.e. E. coli, Klebsiella pneumoniae; and Enterococcus spp. Empirical antibiotic treatment should be targeted once culture and sensitivity results become available. This usually takes 24-48 hours, occasionally even 72 hours. Inadequate antibiotic treatment leads to higher mortality if the etiological agent is of a multi-drug resistant phenotype.\n\nMetallophores are a major virulence factor of bacterial pathogens. These are chelating molecules secreted by the microbe for the uptake of iron, copper, and other metals from the host. E.g., siderophores aim at Fe3+ ions removal from the host protein molecules; the complex then adheres to specific extracellular receptors on the microbial cell and is internalized. Yersiniabactin is another metallophore which binds copper.\n\nProteomic analysis using mass spectrometry has been used in the detection of biomarkers for several pathological conditions: renal failure, post-transplant nephropathy, various malignancies etc. Metallophores can be detected by mass spectrometry.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Patients presenting to the department of urology and fulfilling eligibility criteria.', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* in-patient with clinical signs and symptoms of AP/cUTI or out-patient with clinical signs and symptoms of acute uncomplicated pyelonephritis or in-patient with no clinical signs of UTI and a negative standard urine culture result\n\nExclusion Criteria:\n\n* inability to consent'}, 'identificationModule': {'nctId': 'NCT05674032', 'briefTitle': 'Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis', 'organization': {'class': 'OTHER', 'fullName': 'Thomayer University Hospital'}, 'officialTitle': 'Detection of Causative Agents of Acute Pyelonephritis Using Bacterial Metallophores', 'orgStudyIdInfo': {'id': 'TUH00064190'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Cases', 'description': 'In-patients with AP or cUTI admitted for treatment to the hospital.'}, {'label': 'Control group 1', 'description': 'Out-patients seeking treatment for uncomplicated acute cystitis.'}, {'label': 'Control group 2', 'description': 'In-patients admitted to the ward without signs and symptoms of a urinary tract infection and with a negative urine culture result.'}]}, 'contactsLocationsModule': {'locations': [{'zip': '14059', 'city': 'Prague', 'status': 'RECRUITING', 'country': 'Czechia', 'contacts': [{'name': 'Jan Hrbacek, PhD.', 'role': 'CONTACT', 'email': 'jan.hrbacek@ftn.cz', 'phone': '+420261083688'}, {'name': 'Jiri Stejskal, M.D.', 'role': 'CONTACT', 'email': 'jiri.stejskal@ftn.cz', 'phone': '+420261083688'}, {'name': 'Jan Hrbacek, PhD.', 'role': 'PRINCIPAL_INVESTIGATOR'}, {'name': 'Jiri Stejskal, M.D.', 'role': 'SUB_INVESTIGATOR'}], 'facility': 'Thomayer University Hospital', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}], 'centralContacts': [{'name': 'Jan Hrbacek, PhD.', 'role': 'CONTACT', 'email': 'honzahrbacek@gmail.com', 'phone': '+420261083688'}, {'name': 'Roman Zachoval, Prof.', 'role': 'CONTACT', 'email': 'roman.zachoval@ftn.cz', 'phone': '+420261083688'}], 'overallOfficials': [{'name': 'Jan Hrbacek, PhD.', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Thomayer University Hospital'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Thomayer University Hospital', 'class': 'OTHER'}, 'collaborators': [{'name': 'Czech Academy of Sciences', 'class': 'OTHER'}], 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal Investigator', 'investigatorFullName': 'Jan Hrbacek, M.D.', 'investigatorAffiliation': 'Thomayer University Hospital'}}}}